(VIANEWS) – Navios Maritime Partners LP (NMM), Ultrapar Participacoes S.A. (UGP), ServiceNow (NOW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Navios Maritime Partners LP (NMM)
161.8% sales growth and 19.75% return on equity
Navios Maritime Partners L.P. owns and operates dry cargo vessels in Asia, Europe, North America, and Australia.
Navios Maritime Partners LP’s sales growth this year is anticipated to be 159.8% and 22.9% for next year.
Year-on-year quarterly revenue growth grew by 226.6%, now sitting on 350.8M for the twelve trailing months.
Volume
Today’s last reported volume for Navios Maritime Partners LP is 700164 which is 53.32% above its average volume of 456657.
Navios Maritime Partners LP’s sales growth for the next quarter is 161.8%. The company’s growth estimates for the ongoing quarter and the next is 320.5% and 197.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.75%.
Volatility
Navios Maritime Partners LP’s last day, last week, and last month’s current volatility was 3.47%, 2.17%, and 3.12%, respectively.
Navios Maritime Partners LP’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.41% (day), 4.51% (last week), and 6.59% (last month), respectively.
Navios Maritime Partners LP’s Stock Yearly Top and Bottom Value
Navios Maritime Partners LP’s stock is valued at $29.14 at 20:22 EST, way under its 52-week high of $36.46 and way above its 52-week low of $5.51.
Navios Maritime Partners LP’s Moving Average
Navios Maritime Partners LP’s worth is higher than its 50-day moving average of $26.66 and above its 200-day moving average of $26.73.
2. Ultrapar Participacoes S.A. (UGP)
38.2% sales growth and 8.47% return on equity
Ultrapar Participações S.A. engages in the gas distribution, fuel distribution, chemicals, storage, and drugstores businesses primarily in Brazil, Mexico, Uruguay, Venezuela, other Latin American countries, the United States, Canada, the Far East, Europe, and internationally.
Ultrapar Participacoes S.A.’s sales growth this year is anticipated to be 22.1% and 8.2% for next year.
Year-on-year quarterly revenue growth grew by 79.7%, now sitting on 96.45B for the twelve trailing months.
Volume
Today’s last reported volume for Ultrapar Participacoes S.A. is 1352950 which is 16.46% above its average volume of 1161680.
Ultrapar Participacoes S.A.’s sales growth is a negative 0% for the current quarter and 38.2% for the next. The company’s growth estimates for the present quarter and the next is 25% and negative -14.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.47%.
Volatility
Ultrapar Participacoes S.A.’s last day, last week, and last month’s current volatility was 6.77%, 2.14%, and 2.45%, respectively.
Ultrapar Participacoes S.A.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.46% (day), 3.87% (last week), and 3.84% (last month), respectively.
Ultrapar Participacoes S.A.’s Stock Yearly Top and Bottom Value
Ultrapar Participacoes S.A.’s stock is valued at $2.66 at 20:22 EST, way below its 52-week high of $4.74 and above its 52-week low of $2.60.
Ultrapar Participacoes S.A.’s Moving Average
Ultrapar Participacoes S.A.’s worth is under its 50-day moving average of $2.95 and way below its 200-day moving average of $3.56.
3. ServiceNow (NOW)
26.6% sales growth and 5.93% return on equity
ServiceNow, Inc. provides enterprise cloud computing solutions that defines, structures, consolidates, manages, and automates services for enterprises worldwide.
ServiceNow’s sales growth this year is anticipated to be 28.9% and 25.2% for next year.
Year-on-year quarterly revenue growth grew by 31.6%, now sitting on 5.17B for the twelve trailing months.
Volume
Today’s last reported volume for ServiceNow is 1138780 which is 10.37% above its average volume of 1031730.
ServiceNow’s sales growth is a negative 0% for the ongoing quarter and 26.6% for the next. The company’s growth estimates for the present quarter and the next is 14% and 25.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.93%.
Volatility
ServiceNow’s last day, last week, and last month’s current volatility was 2.77%, 1.42%, and 1.20%, respectively.
ServiceNow’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.35% (day), 1.84% (last week), and 2.07% (last month), respectively.
ServiceNow’s Stock Yearly Top and Bottom Value
ServiceNow’s stock is valued at $651.03 at 20:22 EST, below its 52-week high of $681.10 and way higher than its 52-week low of $442.71.
ServiceNow’s Moving Average
ServiceNow’s value is above its 50-day moving average of $615.96 and way above its 200-day moving average of $539.56.
4. Catalyst Pharmaceuticals (CPRX)
15.6% sales growth and 49.72% return on equity
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States.
Catalyst Pharmaceuticals’s sales growth this year is expected to be 14.1% and 20.3% for next year.
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.
Volume
Today’s last reported volume for Catalyst Pharmaceuticals is 1384390 which is 46.89% above its average volume of 942442.
Catalyst Pharmaceuticals’s sales growth for the next quarter is 15.6%. The company’s growth estimates for the current quarter and the next is a negative 75.6% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 49.72%.
Volatility
Catalyst Pharmaceuticals’s last day, last week, and last month’s current volatility was 4.19%, 1.79%, and 1.87%, respectively.
Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.19% (day), 3.42% (last week), and 3.68% (last month), respectively.
Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value
Catalyst Pharmaceuticals’s stock is valued at $5.05 at 20:22 EST, way under its 52-week high of $6.24 and way above its 52-week low of $2.88.
Catalyst Pharmaceuticals’s Moving Average
Catalyst Pharmaceuticals’s worth is under its 50-day moving average of $5.53 and below its 200-day moving average of $5.13.
5. Axalta Coating Systems Ltd. (AXTA)
9.9% sales growth and 6.21% return on equity
Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Axalta Coating Systems Ltd.’s sales growth this year is anticipated to be 20.4% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 3.82B for the twelve trailing months.
Volume
Today’s last reported volume for Axalta Coating Systems Ltd. is 2433150 which is 8.27% below its average volume of 2652620.
Axalta Coating Systems Ltd.’s sales growth for the next quarter is 9.9%. The company’s growth estimates for the current quarter and the next is a negative 37.3% and negative -3.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.21%.
Volatility
Axalta Coating Systems Ltd.’s last day, last week, and last month’s current volatility was 3.11%, 1.38%, and 1.15%, respectively.
Axalta Coating Systems Ltd.’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.38% (day), 1.79% (last week), and 1.68% (last month), respectively.
Axalta Coating Systems Ltd.’s Stock Yearly Top and Bottom Value
Axalta Coating Systems Ltd.’s stock is valued at $28.57 at 20:22 EST, way below its 52-week high of $34.20 and way above its 52-week low of $21.43.
Axalta Coating Systems Ltd.’s Moving Average
Axalta Coating Systems Ltd.’s value is below its 50-day moving average of $30.29 and below its 200-day moving average of $30.64.
6. Ameren (AEE)
5.9% sales growth and 10.4% return on equity
Ameren’s sales growth this year is anticipated to be 6.1% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.
Volume
Today’s last reported volume for Ameren is 1574350 which is 43.92% above its average volume of 1093840.
Ameren’s sales growth for the next quarter is 5.9%. The company’s growth estimates for the ongoing quarter and the next is 8.8% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.4%.
Volatility
Ameren’s last day, last week, and last month’s current volatility was 0.99%, 0.77%, and 0.65%, respectively.
Ameren’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.17% (day), 1.32% (last week), and 1.25% (last month), respectively.
Ameren’s Stock Yearly Top and Bottom Value
Ameren’s stock is valued at $83.60 at 20:22 EST, under its 52-week high of $90.77 and way higher than its 52-week low of $69.79.
Ameren’s Moving Average
Ameren’s worth is under its 50-day moving average of $87.34 and above its 200-day moving average of $83.45.
Previous days news about Ameren(AEE)
- Analyst ratings for ameren. According to Business Insider on Friday, 17 September, "Over the past 3 months, 6 analysts have published their opinion on Ameren (NYSE:AEE) stock. ", "According to 6 analyst offering 12-month price targets in the last 3 months, Ameren has an average price target of $89.33 with a high of $92.00 and a low of $87.00."
